We are live on ! Find out more
JIR

James Investment Research Portfolio holdings

AUM $984M
1-Year Est. Return 36.03%
This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+36.03%
3 Year Est. Return
+106.79%
5 Year Est. Return
+132.49%
10 Year Est. Return
+460.95%
AUM
$1.43B
AUM Growth
+$57.7M
Cap. Flow
-$21M
Cap. Flow %
-1.46%
Top 10 Hldgs %
22.03%
Holding
591
New
14
Increased
139
Reduced
170
Closed
76

Sector Composition

Rank Sector Weight
1 Technology 13.55%
2 Financials 10.15%
3 Healthcare 9.52%
4 Industrials 9.3%
5 Consumer Discretionary 8.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHY icon
1
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$41.4M 2.89%
489,558
+18,878
+4% +$1.6M
IEI icon
2
iShares 3-7 Year Treasury Bond ETF
IEI
$17.7B
$36.7M 2.56%
291,927
-67,814
-19% -$8.56M
WMT icon
3
Walmart Inc
WMT
$830B
$34.2M 2.38%
862,437
-41,232
-5% -$1.64M
AAPL icon
4
Apple
AAPL
$4.57T
$33.4M 2.33%
454,880
-63,824
-12% -$4.11M
MSFT icon
5
Microsoft
MSFT
$3.69T
$31.6M 2.21%
200,690
-6,081
-3% -$893K
JPM icon
6
JPMorgan Chase
JPM
$948B
$30.9M 2.16%
221,789
-15,527
-7% -$1.99M
SHV icon
7
iShares 0-1 Year Treasury Bond ETF
SHV
$20.8B
$29M 2.02%
262,098
+52,768
+25% +$5.83M
VZ icon
8
Verizon
VZ
$209B
$27.3M 1.9%
444,230
+12,628
+3% +$762K
IGSB icon
9
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
$26.9M 1.88%
501,546
+21,774
+5% +$1.17M
INTC icon
10
Intel
INTC
$466B
$24.7M 1.72%
412,739
-9,574
-2% -$536K
IEF icon
11
iShares 7-10 Year Treasury Bond ETF
IEF
$43.1B
$23.8M 1.66%
215,507
-186,597
-46% -$20.8M
BBY icon
12
Best Buy
BBY
$18.4B
$23M 1.6%
262,060
-23,973
-8% -$1.83M
PFE icon
13
Pfizer
PFE
$161B
$18.8M 1.31%
506,681
+19,302
+4% +$688K
CE icon
14
Celanese
CE
$4.91B
$18.5M 1.29%
149,905
+11,790
+9% +$1.45M
IWN icon
15
iShares Russell 2000 Value ETF
IWN
$14.6B
$18.3M 1.28%
142,310
+72,478
+104% +$8.96M
ELV icon
16
Elevance Health
ELV
$87.3B
$17.8M 1.24%
59,052
-667
-1% -$184K
AFG icon
17
American Financial Group
AFG
$12B
$17.8M 1.24%
161,915
+1,536
+1% +$164K
CSCO icon
18
Cisco
CSCO
$443B
$17.3M 1.21%
360,725
+10,317
+3% +$480K
IGIB icon
19
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.8B
$17.3M 1.21%
298,188
+43,698
+17% +$2.53M
TLT icon
20
iShares 20+ Year Treasury Bond ETF
TLT
$47B
$16.2M 1.13%
119,805
-55,518
-32% -$7.73M
TSN icon
21
Tyson Foods
TSN
$19.9B
$15.4M 1.08%
169,462
+5,852
+4% +$503K
AFL icon
22
Aflac
AFL
$58.9B
$15.1M 1.05%
285,598
+1,992
+0.7% +$106K
AMGN icon
23
Amgen
AMGN
$238B
$14.3M 1%
59,440
+1,901
+3% +$419K
MDT icon
24
Medtronic
MDT
$118B
$14.3M 1%
126,120
+25,586
+25% +$2.81M
MCD icon
25
McDonald's
MCD
$189B
$14.3M 1%
72,325
-24,238
-25% -$4.81M

Similar funds

James Investment Research's Q4 2019 Portfolio in Review

As of Q4 2019, James Investment Research held 591 positions worth $1.43B, up 4.2% from $1.38B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

James Investment Research's Q4 2019 filing shows 14 new, 139 increased, 170 reduced and 76 closed positions. Its largest new stake was Hillenbrand: 13,198 shares worth $440K. The largest sale was iShares 7-10 Year Treasury Bond ETF, an estimated $20.8M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • James Investment Research's largest Q4 2019 buy was Hillenbrand: 13,198 shares worth $440K.
  • James Investment Research added most to iShares Russell 2000 Value ETF in Q4 2019, an estimated $8.96M increase.
  • James Investment Research's biggest Q4 2019 reduction was iShares 7-10 Year Treasury Bond ETF, cutting an estimated $20.8M.
  • James Investment Research fully exited BlackRock Enhanced Equity Dividend Trust in Q4 2019, selling an estimated $2.97M.
  • James Investment Research's ten largest holdings make up 22% of its $1.43B portfolio in Q4 2019.
  • James Investment Research opened 14 new positions and closed 76 in Q4 2019.
  • James Investment Research's portfolio value rose 4.2% quarter-over-quarter to $1.43B.

Based on James Investment Research's 13F filing for Q4 2019, filed 24 Jan 2020.